Alterations in the expression of Nrf2 and Keap1 and the dysregulation of the Nrf2/ARE signaling program have been observed in ALS cellular and animal models and confirmed in human ALS tissue [229,230,231]. This evidence concerns the gene NFE2L2 and amyotrophic lateral sclerosis.